About this Research Topic
This Research Topic is the third volume of the “Reducing Adverse Effects of Cancer Immunotherapy” Community Series. Please see Volume I hereand Volume II here.
In the field of oncology, chemotherapy and radiotherapy have been foundational in the treatment of cancer, yet they bring severe adverse effects such as fatigue, hair loss, nausea, and more. These side effects not only degrade quality of life but also introduce significant healthcare costs and affect both the physical and emotional health of patients. Even more concerning is the potential reduction in therapeutic efficacy due to the necessity of lowering treatment doses in response to severe side effects.
This Research Topic aims to explore and develop new methods to manage and reduce the adverse effects associated with oncologic treatments. By focusing on the management of these side effects, the goal is to sustain treatment efficacy while improving patient comfort and overall quality of life during therapy.
To advance this field, our aim is narrowly focused on the management and alleviation of side effects without compromising the effectiveness of the primary cancer treatment. We welcome original research papers, reviews, mini-reviews, expert commentaries and perspective articles dealing with, but not limited to, the following subthemes:
o New pharmacological agents aimed at side effect mitigation
o Innovative therapeutic strategies to improve treatment tolerability
o Preventive measures to shield patients against severe treatment-related toxicity
o Integration of novel technologies in tracking and managing side effects in real-time
This article collection hopes to catalyze significant advancements in the field of oncologic therapy management, ensuring better care standards and patient survival rates.
Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by robust and relevant validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this topic.
In the field of oncology, chemotherapy and radiotherapy have been foundational in the treatment of cancer, yet they bring severe adverse effects such as fatigue, hair loss, nausea, and more. These side effects not only degrade quality of life but also introduce significant healthcare costs and affect both the physical and emotional health of patients. Even more concerning is the potential reduction in therapeutic efficacy due to the necessity of lowering treatment doses in response to severe side effects.
This Research Topic aims to explore and develop new methods to manage and reduce the adverse effects associated with oncologic treatments. By focusing on the management of these side effects, the goal is to sustain treatment efficacy while improving patient comfort and overall quality of life during therapy.
To advance this field, our aim is narrowly focused on the management and alleviation of side effects without compromising the effectiveness of the primary cancer treatment. We welcome original research papers, reviews, mini-reviews, expert commentaries and perspective articles dealing with, but not limited to, the following subthemes:
o New pharmacological agents aimed at side effect mitigation
o Innovative therapeutic strategies to improve treatment tolerability
o Preventive measures to shield patients against severe treatment-related toxicity
o Integration of novel technologies in tracking and managing side effects in real-time
This article collection hopes to catalyze significant advancements in the field of oncologic therapy management, ensuring better care standards and patient survival rates.
Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by robust and relevant validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this topic.
Keywords: Chemotherapy side effects, radiotherapy side effects, chemotherapy toxicity, cancer treatment toxicity, chemotherapy tolerability
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
